Biomaterial Database

[Preliminary evaluation of Sulpiride, a new psychotropic drug]. 1971

A Bilikiewicz, and S Góra

UI	MeSH Term	Description	Entries
D007273	Injections, Intramuscular	Forceful administration into a muscle of liquid medication, nutrient, or other fluid through a hollow needle piercing the muscle and any tissue covering it.	Intramuscular Injections,Injection, Intramuscular,Intramuscular Injection
D007279	Injections, Subcutaneous	Forceful administration under the skin of liquid medication, nutrient, or other fluid through a hollow needle piercing the skin.	Subcutaneous Injections,Injection, Subcutaneous,Subcutaneous Injection
D008297	Male		Males
D008875	Middle Aged	An adult aged 45 - 64 years.	Middle Age
D011759	Pyrrolidines	Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH.	Tetrahydropyridine,Tetrahydropyridines
D002648	Child	A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL.	Children
D002908	Chronic Disease	Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).	Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D003863	Depression	Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders.	Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D004361	Drug Tolerance	Progressive diminution of the susceptibility of a human or animal to the effects of a drug, resulting from its continued administration. It should be differentiated from DRUG RESISTANCE wherein an organism, disease, or tissue fails to respond to the intended effectiveness of a chemical or drug. It should also be differentiated from MAXIMUM TOLERATED DOSE and NO-OBSERVED-ADVERSE-EFFECT LEVEL.	Drug Tolerances,Tolerance, Drug,Tolerances, Drug
D005260	Female		Females

Related Publications

A Bilikiewicz, and S Góra

[Sulpiride: a new psychotropic compound].

June 1974, Harefuah,

A Bilikiewicz, and S Góra

[An original psychotropic drug: sulpiride].

April 1969, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,

A Bilikiewicz, and S Góra

Action of a new psychotropic drug (sulpiride) on avoidance behavior in rats.

January 1974, Psychopharmacologia,

A Bilikiewicz, and S Góra

Preliminary evaluation of a new psychotropic drug, lenperone, in the treatment of acute schizophrenia.

January 1977, Current medical research and opinion,

A Bilikiewicz, and S Góra

Clinical evaluation of a new psychotropic drug--molindone.

January 1970, Internationale Zeitschrift fur klinische Pharmakologie, Therapie, und Toxikologie. International journal of clinical pharmacology, therapy, and toxicology,

A Bilikiewicz, and S Góra

Pharmacological evaluation of minaprine dihydrochloride, a new psychotropic drug.

January 1982, Arzneimittel-Forschung,

A Bilikiewicz, and S Góra

[Sulpiride in psychiatric practice: a psychotropic drug in a class by itself].

November 1979, Lille medical : journal de la Faculte de medecine et de pharmacie de l'Universite de Lille,

A Bilikiewicz, and S Góra

[Clinical study of a psychotropic drug: sulpiride in attempted suicide without psychosis].

June 1970, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,

A Bilikiewicz, and S Góra

[Carpipramine, a new psychotropic drug].

January 1979, Annales medico-psychologiques,